efficiency by 11%. The quality of formula protein, specifically an increased whey-to-casein ratio, an increased α-lactalbumin content, or a higher tryptophan content increased the energetic efficiency by about 13%. We conclude that fat absorption and protein quality have the potential to modulate energetic efficiency and may contribute to the observed differences in growth and metabolism between breast-fed and formula-fed infants.
Introduction
Compared to breast-fed (BF) infants, the energy requirements of formula-fed (FF) infants are about 15% higher at the age of 1 month and about 7% higher at the age of 6 months [1] . Observational data indicate that energetic efficiency (EE; growth-weight gain or length gain per 100 kcal) is 11% higher in BF infants than in FF infants [2, 3] . Limited data is available on the relationship between the composition of infant formulae and their corresponding EE for growth. However, FF infants consume up to 26% more energy and show higher mean weight gains than BF infants [3] . This higher early weight gain velocity has been associated with an increased risk of obesity and type 2 diabetes in later life [4] [5] [6] [7] [8] .
We observed differences in EE in a study on 213 healthy term infants who were randomized to either a reduced-protein infant formula with a higher α-lactalbumin (ALAB) content and added long-chain polyunsaturated fatty acids (LC-PUFA) or a control formula (CF) with a standard protein content without LC-PUFA until the age of 120 days [9] . The mean daily weight gain was tendentially higher at 30.2 g in the reduced-protein group than in the control group (28.3 g ). Infants in the reducedprotein group consumed significantly less energy during the study period (490 vs. 531 kcal/day). Thus, the EE for weight was about 12% higher in infants who received the reduced-protein formula with ALAB and LC-PUFA, which we considered to be induced by different dietary protein and amino acid compositions [9] .
This finding prompted us to review the available data on the effects of macronutrients of infant formulae on EE in fully FF infants during the first months of life. We aimed to identify the relationship of infant formula composition with EE for growth and searched for effects of macronutrient contents and of modified protein, fat, and carbohydrate sources. The studies included in the review met the following criteria: (1) the effect of an infant formula was investigated, (2) weight and length and energy intake were evaluated, (3) an FF control group was included, and (4) participants were apparently healthy infants born at term ( ≥ 37 weeks of gestation) with a normal weight (>2,500 g at birth or a weight above the 5th percentile of WHO growth charts) and were fully FF (contribution of other foods was <25% of the energy intake).
Full-text articles which met these inclusion criteria were extracted into an EndNote database (EndNote X5; Thomson Reuters, Philadelphia, Pa., USA). Information on methods, populations, interventions, growth, and nutritional intakes was collected. If the mean weight, length gain, and dietary intake were not reported in grams/ day, millimeters/day, and kilocalories/day, respectively, they were calculated using reported data. If the growth or dietary intake could not be calculated from reported data, the study was excluded from analysis. Additionally, the study of Fleddermann et al. [9] was considered in the analysis and used as an additional reference. Growth and energy intakes were compared between intervention and control groups for all included studies. When the dietary intake was reported in kilocalories/kilogram of body weight, the mean dietary energy intake was calculated using the absolute weight at assessment of the dietary intake. Based on Fleddermann et al. [9] , the EE was calculated as the ratio of weight or length gain (expressed as g/day or mm/day) and the average energy intake per day during a study. EE was expressed as grams/100 kilocalories for weight or as millimeters/100 kilocalories for length.
Results

Selection of Eligible Papers
The literature search yielded 808 references. Of those 808 studies, 620 were excluded on the basis of titles and abstracts not fulfilling our inclusion criteria, while 188 were identified as potentially eligible ( fig. 1 ). In total, 94 studies with a focus on the macronutrient composition of infant formulae were obtained as full-text articles. After a detailed evaluation, 13 studies of different population groups met the inclusion criteria and were included in the analysis. The main reason for exclusion was inadequate reporting of the energy intake or growth.
Baseline Characteristics and Results of the Included Trials
The key characteristics of the included trials are presented in table 1 . All studies assessed growth and energy intake from birth or the first month of life until the ages of 3-6 months. All but 2 studies included infants of both sexes, while Fomon et al. [10] and Carnielli et al. [11] enrolled male infants only. Ten of 14 studies aimed to investigate the suitability and safety of the formulae with a focus on protein and carbohydrate contents [2, 10, [12] [13] [14] [15] [16] [17] [18] [19] , while studies focused on fat composition aimed to investigate fat or mineral balances [11, 20, 21] . Schmelzle et al. [17] and Lasekan et al. [19] studied modified carbohydrate components in formulae. The studies of Koo et al. [20] , Kennedy et al. [21] , and Carnielli et al. [11] investigated formulae with modified fat contents. Most of the included studies focused on the protein component [2, 10, [12] [13] [14] [15] [16] [17] .
In total, the studies evaluated data of 1,561 participants. The duration of the interventions varied from 35 days to 6 months. Further details on the population characteristics, compositions of formulae, and available data of the included studies are shown in table 1 .
Growth and Energy Intake
The observed weight gains were 22.5-35.9 g/day, and length gains varied from 0.87 to 1.59 mm/day ( table 2 ). The anthropometric gains differed between the different study populations and tended to be higher in smaller infants. The highest anthropometric gains (31.7-35.9 g/day or 1.27-1.29 mm/day) were observed in infants who were 8-12 weeks old at the study end, compared to lower gains in infants aged 6 months at the study end (22.5-24.4 g/ day or 0.87-0.99 mm/day).
The energy intake for study formulae varied between 395 and 718 kcal/day ( for the new established and modified intervention formulae (IF) was lower (up to 63 kcal/day) than or similar (maximum 13 kcal/day higher in 3 studies) to the energy intake provided by CF.
Calculated EE
The EE for growth was calculated for all studies and ranged from 3.43 to 7.26 g/100 kcal for weight gain and from 0.14 to 0.37 mm/100 kcal for length gain ( table 2 ). The largest difference in EE between the intervention and control groups of one study (EE of IF minus EE of CF) was observed in 6 of 9 protein-focused studies [2, 9, 13, 14, 16, 17] and in 1 study on fat modification [11] .
There were no consistent effects of the total contents of energy, protein, carbohydrates, or fat on EE. Regarding protein quality, Davis et al. [14] , Fleddermann et al. [9] , and Rozé et al. [13] observed an about 10-12% higher EE for weight with ALAB-enriched formulae. A higher whey-to-casein ratio [12, 13, 15, 17, 20] as well as a higher tryptophan (Trp) content [2, 9] also enhanced the EE. Modifications of the carbohydrate sources of infant formulae resulted in only modest increases in EE of 2-3% when combinations of maltodextrin, sucrose, or corn syrup and lactose were compared to lactose-only formulae [17] [18] [19] . Studies on modification of the fat source, with use of a structured triacylglycerol with preferential esterification of palmitic acid at the sn-2 position, reported an increased EE of 4-11% with a high palmitic acid content at the sn-2 position of triacylglycerols [11, 21] .
Discussion
This review documents the effects of infant formula composition on EE. Intervention trials on infants from birth to 6 months of age were conducted on 1,561 infants. The results showed no effect of total contents of energy, protein, carbohydrates, or fat on EE, but did show effects of macronutrient quality or source.
The results on modification of the carbohydrate source showed no or only a slight impact on EE of 2-4%. This small increase might be related to carbohydrates with a higher glycemic index, such as maltodextrin (glycemic index 80-105), corn syrup (glycemic index 115), sucrose (glycemic index 65), and starch (glycemic index 100), as compared to lactose (glycemic index 46), which may result in elevated blood glucose and insulin levels [22] . We have proposed that elevated insulin levels may induce enhanced infant weight gain and fat deposition and an increased later risk of adiposity and obesity [23] .
The effect of palmitic acid positioning in the dietary triacylglycerol was investigated in studies on fat modification [11, 20, 21] . Palmitic acid is the most abundant saturated fatty acid in human milk triacylglycerols [24] . Use of a structured triacylglycerol with preferential esterification of palmitic acid at the sn-2 ester position instead of the sn-1,3 position increased the EE for weight by about 11% and that for length by about 16% [11] . The sn-2 ester bond is not cleaved during the digestion by pancreatic lipase, and the resulting sn-2 palmitoyl monoacylglycerol is more efficiently absorbed than free palmitic acid [11] , which increases the metabolizable energy.
The major factor influencing EE that we identified is protein quality. Improved protein quality of formulae may result in a lower total energy intake via formula [9, [12] [13] [14] [15] with a sufficient supply of bioavailable essential amino acids. In infant formula, Trp becomes the first limiting amino acid when the protein content is reduced and no free amino acids are added [25] . An adequate supply of Trp can be achieved via the addition of free Trp or an increase in ALAB content. As the predominant whey fraction in human milk, ALAB is the main Trp source in BF infants, and its incorporation into infant formula supports a sufficient supply of essential amino acids including Trp in FF infants [26, 27] . Studies on increased ALAB contents in formulae have shown 11-57 kcal/day lower energy intakes and 0.9-1.9 g/day higher weight gains [9, 13, 14] . Combination of these factors increases the EE for weight by about 0.56-0.78 g/100 kcal. Dietary ALAB is associated with higher plasma Trp concentrations [9, 14] . Since Trp is a precursor of serotonin and melatonin, this might affect appetite regulation, satiety, and the sleep-wake rhythm [28] . If ALAB-rich formulae induce greater satiety, a lower energy intake may result. Further indication of the importance of Trp is obtained from studies which investigated the addition of free Trp to infant formulae. In the study of Hanning et al. [2] , a high Trp content without an increase in the whey-to-casein ratio or the ALAB content resulted in a 63 kcal/day lower energy intake compared to the control group. Trp is more quickly absorbed in its free form than as protein-bound amino acid and may reach tissues such as the brain or liver more rapidly [25] . The resulting increase in the ratio of Trp to the other large neutral amino acids could lead to greater satiety and less formula intake [2] .
Consistent results indicate a strong relationship between a higher whey-to-casein ratio and a higher EE [12, 13, 15, 17] . Whey-dominant formulae have a whey-tocasein ratio (60: 40) similar to that of human milk in early lactation [29] . Whey has a slightly higher protein quality (protein digestibility-corrected amino acid score) than casein and is more easily digested by the gastrointestinal system [30] . Similar effects of higher wheyto-casein ratios on EE are observed with greater contents of intact whey [12, 13, 15] or fully hydrolyzed whey [17] .
Although the increased EE of infant formulae may be considered beneficial, infantile growth should not exceed the growth of BF infants by feeding large volumes of energetically highly efficient formulae. High growth velocities in early infancy have been related to higher adiposity and type 2 diabetes risks in later life [4, 5, 8, 31] . Thus, a potential benefit for infants is derived from consuming smaller amounts of high-quality formula, while achieving adequate growth, and avoiding an additional meta-
